Hormonal Support
PT-141 (Bremelanotide)
Melanocortin receptor agonist for sexual function enhancement
Hormone OptimizationCompare
Dosage
1-2mg as needed
Results
1-2 hours
Frequency
As needed (max 8x/month)
Cost
$100-200/month
Estimated monthly
$100-200
About PT-141 (Bremelanotide)
PT-141 (Bremelanotide) is a melanocortin receptor agonist FDA-approved under the brand name Vyleesi for hypoactive sexual desire disorder. Unlike PDE5 inhibitors, it works through the central nervous system to enhance sexual desire. It was originally derived from the tanning peptide melanotan and affects both men and women.
Administration
Method
Subcutaneous injection
Timing
PM
Food
Any time
Key Benefits
- Enhances sexual desire
- Works for both men and women
- FDA-approved mechanism
- Acts on central nervous system
- Not dependent on blood flow
Important Considerations
- • Uncontrolled hypertension
- • Cardiovascular disease
Additional Notes
- • Take 45-60 min before activity
- • May cause flushing/nausea